Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment

Last updated: January 7, 2016
Sponsor: Azienda USL Ferrara
Overall Status: Completed

Phase

4

Condition

Miscarriage

Treatment

N/A

Clinical Study ID

NCT02601898
ALAvsPROG
  • Ages 24-37
  • Female

Study Summary

The aim of this study was to compare the therapeutic efficacy of lipoic acid versus progesterone by vaginal administration on subchorionic hematoma resorption in women at the first trimester of pregnancy with threatened miscarriage.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age: 24-37

  • Gestational week: 7- 12

  • Evidence of threatened miscarriage (pelvic pain with or without vaginal bleeding)

  • Ultrasound evidence of subchorionic hematoma

Exclusion

Exclusion Criteria:

  • Lack of fetus

  • Absence of fetal heart tone

  • Uterine anomaly or fetal anomaly

  • Presence of multiple pregnancy

  • Gestation pathology

  • Therapies with anti-coagulants or anti-hypertensive drugs

Study Design

Total Participants: 54
Study Start date:
January 01, 2015
Estimated Completion Date:

Connect with a study center

  • Azienda USL Ferrara

    Ferrara,
    Italy

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.